NYZ.F NOVACYT EO-0667

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.4385 EUR
Close of Nov 12, 2026
0.2930 0.9680
Market cap
EUR 31.8M
P/E
-
P/B
1.39x
ROE
-97.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is NYZ.F undervalued?

Graham number

The Graham number of NOVACYT EO-0667 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NOVACYT EO-0667 fundamental analysis

No fundamental analysis for NOVACYT EO-0667 yet.

NOVACYT EO-0667 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NOVACYT EO-0667

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, a…

Full company profile